Harbor Light Capital Partners

Carmell was founded in 2007 to commercialize technology developed jointly at Carnegie Mellon University and Allegheny General Hospital. The proprietary technology enables the manufacture of biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. These plastics are sterile, off-the-shelf, easy to handle, shape and suture, have controlled degradation rates, contain known levels of bioactivity, and exhibit mechanical properties designed to match the repaired tissue. Carmell's plastics can be simply viewed as plastic forms of ultra-concentrated blood clots; they therefore represent the ideal biomaterials, using the body's own growth and regenerative factors to naturally promote tissue healing. The Company is focused on the sports medicine market, with products designed to accelerate healing and produce better clinical outcomes in treating injuries to connective tissue (e.g., tendons, ligaments and cartilage).

Courtagen Life Sciences, Inc. is a biotechnology company based in Woburn, Massachusetts, specializing in genetic testing services. The company provides a range of clinical genetic tests focused on neurological conditions, including developmental delay, intellectual disability, autism spectrum disorders, epilepsy, and mitochondrial disorders. Its offerings include comprehensive analyses such as epiSEEK Comprehensive and epiSEEK Focus, which assess genes associated with neurological function and seizure disorders, respectively. Additionally, Courtagen offers tests for drug metabolism related to epilepsy, as well as panels for neurodevelopmental and lysosomal storage disorders. The company also provides next generation sequencing services to support research in target discovery, clinical development, and companion diagnostics. Founded in 2003, Courtagen Life Sciences aims to empower physicians, families, and children affected by neurological disorders through advanced genetic insights.

Senet Inc., established in 2006 and headquartered in Portsmouth, New Hampshire, specializes in Internet of Things (IoT) connectivity solutions. The company offers a range of services including network-as-a-service, managed network, low power wide area virtual network, geolocation services, along with network planning and management tools. Senet's offerings enable businesses to connect devices over long ranges, delivering cost-effective, highly scalable networks for managing distributed assets. Their subscription-based SaaS applications facilitate data-driven decision-making in industries such as fuel oil and propane tank automation, water and gas metering, and solar irradiance monitoring.

Carmell was founded in 2007 to commercialize technology developed jointly at Carnegie Mellon University and Allegheny General Hospital. The proprietary technology enables the manufacture of biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. These plastics are sterile, off-the-shelf, easy to handle, shape and suture, have controlled degradation rates, contain known levels of bioactivity, and exhibit mechanical properties designed to match the repaired tissue. Carmell's plastics can be simply viewed as plastic forms of ultra-concentrated blood clots; they therefore represent the ideal biomaterials, using the body's own growth and regenerative factors to naturally promote tissue healing. The Company is focused on the sports medicine market, with products designed to accelerate healing and produce better clinical outcomes in treating injuries to connective tissue (e.g., tendons, ligaments and cartilage).

Alcyone Lifesciences, Inc. is a biotechnology company based in Lowell, Massachusetts, established in 2010. It specializes in developing innovative treatment modalities for oncology and chronic neurological conditions, focusing on addressing the unmet needs related to molecular therapy in the brain. The company has created advanced micro-fabricated delivery systems, such as the Alcyone MEMS Cannula system, which allows neurosurgeons to precisely navigate and deliver therapeutic agents to targeted areas under real-time MRI guidance. This technology is particularly significant for treating various neurological disorders, including brain tumors, hydrocephalus, epilepsy, and neurodegenerative diseases. By optimizing drug delivery across the blood-brain barrier, Alcyone Lifesciences aims to enhance the effectiveness of therapies for chronic neuropathological conditions and improve outcomes for patients with rare and orphan disorders.

Terascala, headquartered in Boston, is a developer of advanced storage appliances designed to enhance the speed and efficiency of data processing for organizations engaged in simulation, analysis, and modeling. By providing high-performance storage solutions, Terascala enables companies to achieve faster insights, facilitating the development and launch of new products and innovations. Their storage appliances deliver on-demand throughput at multiple gigabytes per second, ensuring optimal performance while utilizing leading storage platforms for long-term data protection. Terascala’s products are exclusively available through strategic partnerships with major technology firms, including Dell, EMC, and NetApp.

EnerTrac, Inc. is a company based in Portsmouth, New Hampshire, specializing in fuel delivery and monitoring solutions for fuel dealers. Founded in 2009, EnerTrac develops advanced tank monitoring systems that automate the measurement and monitoring of fuel oil and propane tanks, transitioning from traditional manual methods to more efficient automated processes. The company's innovative low-frequency monitoring network provides actionable data to delivery companies, allowing them to optimize delivery schedules based on real-time tank levels. EnerTrac's technology not only enhances the efficiency of fuel delivery but also contributes to fuel savings and emission reductions. The system includes a range of components such as tank monitors, cloud software, mobile applications, and remote monitoring kits, with the potential to expand into additional applications like thermostats and HVAC systems. EnerTrac operates as a subsidiary of WESROC Monitoring Solutions as of December 2017.

Draker is a company that specializes in providing monitoring, management, and control solutions for commercial and utility solar energy systems. With over a decade of experience, Draker offers a comprehensive range of products and services designed to enhance the efficiency and profitability of photovoltaic (PV) assets for developers, owners, and operators. Their solutions include project-based services, field instrumentation, data collection and management systems, and advanced web applications featuring analytical tools. Additionally, Draker offers public information displays to ensure comprehensive oversight of solar energy performance. Through these capabilities, Draker enables enterprises to maximize the effectiveness of their green power technologies and effectively manage their solar energy portfolios.

Vets First Choice provides veterinary practices with an online pharmacy and home delivery services. It partners with veterinarians to create insight into gaps in patient care and offer professionalized pro-active prescription management to drive client engagement and improve compliance. The company was founded by Ben Shaw in 2010 and is based in Portland, Maine.

Courtagen Life Sciences, Inc. is a biotechnology company based in Woburn, Massachusetts, specializing in genetic testing services. The company provides a range of clinical genetic tests focused on neurological conditions, including developmental delay, intellectual disability, autism spectrum disorders, epilepsy, and mitochondrial disorders. Its offerings include comprehensive analyses such as epiSEEK Comprehensive and epiSEEK Focus, which assess genes associated with neurological function and seizure disorders, respectively. Additionally, Courtagen offers tests for drug metabolism related to epilepsy, as well as panels for neurodevelopmental and lysosomal storage disorders. The company also provides next generation sequencing services to support research in target discovery, clinical development, and companion diagnostics. Founded in 2003, Courtagen Life Sciences aims to empower physicians, families, and children affected by neurological disorders through advanced genetic insights.

Draker is a company that specializes in providing monitoring, management, and control solutions for commercial and utility solar energy systems. With over a decade of experience, Draker offers a comprehensive range of products and services designed to enhance the efficiency and profitability of photovoltaic (PV) assets for developers, owners, and operators. Their solutions include project-based services, field instrumentation, data collection and management systems, and advanced web applications featuring analytical tools. Additionally, Draker offers public information displays to ensure comprehensive oversight of solar energy performance. Through these capabilities, Draker enables enterprises to maximize the effectiveness of their green power technologies and effectively manage their solar energy portfolios.

Carmell was founded in 2007 to commercialize technology developed jointly at Carnegie Mellon University and Allegheny General Hospital. The proprietary technology enables the manufacture of biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. These plastics are sterile, off-the-shelf, easy to handle, shape and suture, have controlled degradation rates, contain known levels of bioactivity, and exhibit mechanical properties designed to match the repaired tissue. Carmell's plastics can be simply viewed as plastic forms of ultra-concentrated blood clots; they therefore represent the ideal biomaterials, using the body's own growth and regenerative factors to naturally promote tissue healing. The Company is focused on the sports medicine market, with products designed to accelerate healing and produce better clinical outcomes in treating injuries to connective tissue (e.g., tendons, ligaments and cartilage).

Micronotes Inc., established in 2008 and based in Boston, Massachusetts, operates as a digital marketing SaaS company specializing in cross-sell technology solutions for financial institutions. The company offers an AI-enabled cloud-based platform that enhances customer engagement through automated digital interviews, leveraging machine learning to analyze customer data and deliver tailored product offers across various digital channels. Their suite of tools includes Cross-Sell Engine, Social Media Targeting, Mobile-SMS Referrals, Net Promoter Score Measurement, and predictive analytics for anticipating customer needs.

Eggrock Partners, Inc. operates as a consulting and systems integration company that focuses on delivering e-business solutions to emerging enterprises. The company is based in Concord, Massachusetts. As of March 31, 2000, Eggrock Partners, L.L.C. is a subsidiary of Breakaway Solutions, Inc.

FetchDog is an online destination for dog owners to shop, learn and socialize. They offer passionate dog people a place to find quality dog supplies and credible advice on their dog’s health and wellness. Their products include pets, dog beds, dog homes, dog collars, leashes and harnesses, dog apparel, dog toys, treats, bowls, dog travel, and more.

Draker is a company that specializes in providing monitoring, management, and control solutions for commercial and utility solar energy systems. With over a decade of experience, Draker offers a comprehensive range of products and services designed to enhance the efficiency and profitability of photovoltaic (PV) assets for developers, owners, and operators. Their solutions include project-based services, field instrumentation, data collection and management systems, and advanced web applications featuring analytical tools. Additionally, Draker offers public information displays to ensure comprehensive oversight of solar energy performance. Through these capabilities, Draker enables enterprises to maximize the effectiveness of their green power technologies and effectively manage their solar energy portfolios.